D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,324
- Value
- $344.9K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,324 | $344.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 6,324 | $300.8K | <0.1% | +353+5.9% | Added | Holders |
| Q4 2025 | 5,971 | $313.1K | <0.1% | +592+11.0% | Added | Holders |
| Q3 2025 | 5,379 | $348.6K | <0.1% | +5,379 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −2,942−100.0% | Sold out | Holders |
| Q3 2021 | 2,942 | $329.0K | <0.1% | +356+13.8% | Added | Holders |
| Q2 2021 | 2,586 | $419.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 2,586 | $315.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.